Zanubrutinib Related Compound 1
USP related compound reference standard
Specifications
- Product name
- Zanubrutinib Related Compound 1
- CAS number
- 2215-77-2
- Catalogue number
CP128045- Molecular formula
- C13H10O3
- Molecular weight
- 214.22
- Purity (HPLC)
- >95%
- Physical form
- White Powder
- Storage
- 2-8 °C
- SMILES
O(C1C=CC=CC=1)C1C=CC(C(O)=O)=CC=1- Available pack sizes
- Quoted on request
- Lead time
- In stock
- Intended use
- Related substances and impurity testing, method development and validation, system suitability, QC release and stability testing.
Fields shown as — are not published for this item. They are left blank rather than filled with an estimate.
Description
Zanubrutinib Related Compound 1 (CAS 2215-77-2) is supplied by ImpurityLab as a United States Pharmacopeia related compound standard, identified against the monograph for its parent substance. Catalogue number CP128045.
The material is issued against molecular formula C13H10O3, molecular weight 214.22 g mol−1, physical form described as white powder.
Structural notation: O(C1C=CC=CC=1)C1C=CC(C(O)=O)=CC=1
Letter designations are assigned inside a monograph for one named substance. The same molecule can carry a different letter, or a different style of name, in another pharmacopoeia. Map the material from its structure — chemical name, formula and CAS — rather than from the letter alone.
Storage. Store at 2-8 °C. Allow the container to reach room temperature before opening so that moisture does not condense onto the material. Record the date of first opening on the label.
Pack sizes. Quoted on request. Non-standard quantities are quoted on request, normally within two working days.
Documentation. Each lot is released with a certificate of analysis that states the assay method, the water content and the form as supplied. The safety data sheet is available with the same lot number. Quote catalogue number CP128045 when requesting either document.
Documentation
Documents are issued per lot. The COA you receive describes the lot that ships, not a representative sample.
Regulatory reference
Zanubrutinib Related Compound 1. Confirm the acceptance criterion, the reporting threshold and the edition of the monograph against your own method before use.
References are provided to help you map a standard to a pharmacopoeial method. Confirm the acceptance criteria against your own method before use.